About Cytrellis
Cytrellis is a Healthcare company based in Boston (United States) founded in 2012. Developer of aesthetic devices for scar reduction and skin tightening. Cytrellis has raised $111.22 million across 7 funding rounds from investors including Arch Venture Partners, PFM Health Sciences and Sands Capital Ventures. The company has 59 employees. Cytrellis offers products and services including ellacor. Its focus areas include Life Sciences, Dermatology, Medical Devices and Therapeutic Devices. Its legal entity is CYTRELLIS BIOSYSTEMS, INC. Its competitors include Procell Therapies, Altair Instruments and Dermaglow Microdermabrasion.
Company details
Cytrellis was founded in 2012 in Boston, United States, as a clinical-stage med-tech company focused on dermatology and aesthetic medicine. A proprietary class of devices is being developed to tighten and manipulate skin without surgery, while sagging skin linked to aging is addressed without incisions or scarring. Operations involve collaboration with physicians and partners to create solutions prioritizing safety, clinical outcomes, and enhanced quality of life for patients.
- Headquarters Boston, United States
- Employees 59
- SectorsHealthcare
- Email••••••••
- Website cytrellis.com
- Social LinkedIn Facebook
- Legal Name Cytrellis Biosystems, Inc.
- Total Equity Funding$111.22M (USD)
in 7 rounds
- Latest Funding Round$25.13M (USD), Series C
Dec 2024
- InvestorsArch Venture Partners
& 6 more
- Employee Count59
Products & Services of Cytrellis
Cytrellis offers a comprehensive portfolio of products and services, including ellacor.
System for micro-scale removal of sagging skin.
Funding Insights of Cytrellis
Cytrellis has successfully raised a total of $111.22M across 7 strategic funding rounds. The most recent funding activity was a Series C round of $25.13 million completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $111.22M
- Total Rounds 7
- Last Round Series C — $25.13M
- First Round $450,000
(Dec 2012)
- Investors Count 7
All 7 funding rounds of Cytrellis with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2024 | $25.13M | Series C | – | – | – |
| Jan 2021 | $50M | Series C | – | Arch Venture Partners, PFM Health Sciences | – |
| Jun 2018 | $28.5M | Series B | – | – | |
| Apr 2016 | Series A | – | – | ||
| Feb 2015 | $7.14M | Series A | – | – | – |
| Mar 2013 | $1M | Debt – Venture | – | – | |
| Dec 2012 | $450,000 | Seed | – | – | – |
7 investors in total: 7 institutional.
Investors in Cytrellis
Cytrellis has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Arch Venture Partners, PFM Health Sciences and Sands Capital Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm focused on life science companies | 1986 | archventure.com | Chicago, United States | |
Healthcare companies are invested in by this private equity firm. | pfmhealthsciences.com | San Francisco, United States | ||
Growth stage tech & life sciences focused VC Firm investing in Asia and the US | sandscapitalventures.com | Arlington, United States | ||
Early-stage tech and life sciences focused VC firm investing primarily in the US | biomaticscapital.com | Seattle, United States | ||
Life sciences innovation is supported through funding and programs. | masslifesciences.com | Waltham, United States | ||
Healthcare investment advisory services are provided by PFM Health Sciences. | 2004 | pfmlp.com | San Francisco, United States | |
Merz is recognized as a leader in aesthetic medicine and neurotoxin therapy. | 1918 | merz.com | Frankfurt am Main, Germany |
Investor details for Cytrellis
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Cytrellis
22 people are tracked at Cytrellis (4 in leadership, 8 in board & advisors, 10 in team); the tracked headcount is 59.
| Name | Role | Group |
|---|---|---|
Derek Sheldon | Director Of Information Technology | Leadership |
Anthony Mullin | VP, Clinical Operations | Leadership |
Robert Hinz | VP, Operations | Leadership |
Kate Allen | District Sales Director - South Region *president's Club Winner | Leadership |
John McDonough | Chairman | Board & advisors |
Frederick C. Beddingfield, III | Director | Board & advisors |
Doug Levinson | Founder | Board & advisors |
Keith L. Crandell | Director | Board & advisors |
Fred Aslan | Director | Board & advisors |
Brent Hauser | Director | Board & advisors |
Rox Anderson | Founder & Advisor | Board & advisors |
William Gerald Austen | Founder & Advisor | Board & advisors |
Kelly M. | Area Sales Manager | Team |
Brian Dixon | Senior Manager Quality Operations | Team |
Manasi Arora | Platform Product Lead | Team |
CJ Sander | Sr. Marketing Communications Manager | Team |
Lynne Brunaccini | Senior Manager, Customer Service | Team |
Scott Pratt | Area Sales Manager | Team |
Mario Leone | Area Sales Manager | Team |
Jennifer Abbott | Accounting Manager | Team |
2 more people are available in the full profile.
Complete people profiles for Cytrellis
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Cytrellis
3 dated milestones of Cytrellis across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Cytrellis is founded.
- Funding First funding round of $450K.
- Funding Latest funding round, Series C, of $25.1M.
Competitors of Cytrellis
Cytrellis has 3 listed competitors in our database. They include Procell Therapies, Altair Instruments and Dermaglow Microdermabrasion.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| procelltherapies.com | 2013 | Austin, United States | 5 | Microneedling and dermabrasion systems are developed for aesthetic procedures. | ||
| altairinstruments.com | 1981 | Ventura, United States | Offers microdermabrasion machines, wands, and serums for professional skin treatments worldwide. | |||
| dermaglow.com | 1998 | Novato, United States | Manufactures microdermabrasion devices with support and financing for skincare professionals. |
Detailed competitors of Cytrellis
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Cytrellis
The website of Cytrellis (cytrellis.com) receives about 3K visits a month.
- Monthly visits3K
▲ 42.8% vs previous month
Top companies in Dermatology
3 companies that operate in the same segment as Cytrellis (Dermatology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Neurotoxin products for aesthetic and therapeutic skin treatments are developed. | 2002 | Newark, New Jersey, United States | USD 154.56 M | USD 234.04 M | 597 | |
Diagnostic tests for cancer prognosis are provided. | 2008 | Friendswood, Texas, United States | USD 61.97 M | USD 344.23 M | 761 | |
Adhesive patch biopsies for skin cancer detection are provided. | 1996 | San Diego, California, United States | USD 24.37 M | USD 15.3 M | 259 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cytrellis
Complete news archive for Cytrellis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cytrellis
Cytrellis was founded in 2012.
Cytrellis is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Cytrellis is a funded company, having raised a total of $111.22M across 7 funding rounds to date. The company's 1st funding round was a Seed of $450K, raised on Dec 2012.
Cytrellis has 59 employees.
Cytrellis was founded in 2012 in Boston, United States, as a clinical-stage med-tech company focused on dermatology and aesthetic medicine. A proprietary class of devices is being developed to tighten and manipulate skin without surgery, while sagging skin linked to aging is addressed without incisions or scarring. Operations involve collaboration with physicians and partners to create solutions prioritizing safety, clinical outcomes, and enhanced quality of life for patients.
Cytrellis's top competitors include Procell Therapies, Altair Instruments and Dermaglow Microdermabrasion.
Cytrellis offers ellacor.
Cytrellis has 7 investors. Key investors include Arch Venture Partners, PFM Health Sciences, Sands Capital Ventures, PFM Health Sciences, and Merz.
Cytrellis operates through Cytrellis Biosystems, Inc..